{
    "2020-12-11": [
        [
            {
                "time": "",
                "original_text": "能否用分类表决机制决定沃森生物上海泽润的去留",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "上海泽润",
                        "分类表决机制"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "五日龙虎榜追踪 机构抢筹这36股",
                "features": {
                    "keywords": [
                        "龙虎榜",
                        "机构抢筹",
                        "36股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "云南药用生物资源6559种占全国总量51% 已孕育云南白药一心堂等7家上市药企",
                "features": {
                    "keywords": [
                        "云南药用生物资源",
                        "云南白药",
                        "一心堂",
                        "上市药企"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物86页长文回应：否认存在利益输送 意见分歧是沟通不到位",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "利益输送",
                        "意见分歧",
                        "沟通不到位"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}